wire - news in brief

Page not found (Error 404)

Life Sciences - Jan 16
Life Sciences
Using the fossil and fossilized footprints of a 300-million-year-old animal, an interdisciplinary team that includes scientists from EPFL and Humboldt-Universitšt zu Berlin have developed a method for identifying the most likely gaits of extinct animals and designed a robot that can recreate their walk.
Business - Jan 16

Nudging, the concept of influencing people's behavior without imposing rules, bans or coercion, is an idea that government officials and marketing specialists alike are keen to harness, and itis often viewed as a one-size-fits-all solution.

Physics - Jan 15

Geneva. Today, the Future Circular Collider†(FCC) collaboration submitted its Conceptual Design Report (CDR) for publication, a four-volume document that presents the different options for a large circular collider of the future.


Results 1 - 50 of 330.
1 2 3 4 5 7 Next »

Pharmacology - Health - 07:30
FDA accepts Roche’s supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) for Tecentriq (atezolizumab) in combination with Abra

Environment - 15.01.2019
Carbon cycles as a yardstick for climate change
Carbon cycles as a yardstick for climate change
The study by 153 researchers from 40 countries found that climate factors such as temperature and humidity strongly influence the carbon cycles of river ecosystems.

Health - Materials Science - 15.01.2019
Ears from the 3D-printer
Ears from the 3D-printer
Cellulose obtained from wood has amazing material properties. Empa researchers are now equipping the biodegradable material with additional functionalities to produce implants for cartilage diseases using 3D printing.

Health - Life Sciences - 15.01.2019

Environment - Life Sciences - 15.01.2019
EPFL goes to New Zealand to study melting glaciers
Four EPFL researchers will explore New Zealand's glacier-fed streams for two months, marking the first step in a global journey that will take them across 15 countries by 2021.

Innovation / Technology - Business / Economics - 11.01.2019
EPFL drones draw crowds in Las Vegas
EPFL drones draw crowds in Las Vegas
This week, four EPFL-designed drones are being shown in the Swiss Pavilion at the Consumer Electronics†Show in Las Vegas.

Innovation / Technology - 10.01.2019

Event - Business / Economics - 09.01.2019

Life Sciences - 09.01.2019
Change of Teeth Causes Yo-Yo Effect in Elephants' Weight
Change of Teeth Causes Yo-Yo Effect in Elephants’ Weight
The weight of elephants living in zoos fluctuates over the course of their adult lives in cycles lasting around a hundred months, researchers at the University of Zurich have found. The fluctuation is linked to the particular pattern of tooth change in elephants, which results in them having more or less chewing surface available.

Pharmacology - Health - 08.01.2019
Novartis investigational therapy crizanlizumab (SEG101) receives FDA Breakthrough Therapy designation for the prevention of vaso-occlusive crises in sickle cell disease
Crizanlizumab is a monthly infusion under development to prevent pain crises (also called vaso-occlusive crises, or VOCs) in patients with sickle cell disease † Sickle cell VOCs, which are triggered

Pharmacology - Health - 07.01.2019
Sandoz and Pear Therapeutics Announce US Launch of reSET-OTM to Help Treat Opioid Use Disorder
ReSET-O(TM)* is the first US FDA-cleared prescription digital therapeutic for patients with Opioid Use Disorder Cleared by the FDA in December, reSET-O is available immediately As part of a broader f

Innovation / Technology - Careers / Employment - 07.01.2019
Eleven EPFL startups in Las Vegas
Eleven EPFL startups in Las Vegas
This week, eleven EPFL startups are in Las Vegas to tout their technologies at the Consumer Electronics Show, one of the largest events of its kind.

Innovation / Technology - Health - 04.01.2019

Life Sciences - Physics - 02.01.2019
Pushing the boundaries of the visible
Our cutting-edge technology platforms are key enablers of research at the FMI. One of the biggest of these, with the largest number of users, is the Facility for Advanced Imaging and Microscopy (FAIM). To find out more about the facility, and microscopy in general, we spoke to the joint heads of FAIM - Christel Genoud, who is responsible for Electron Microscopy, and Laurent Gelman, responsible for Light Microscopy.

Health - Pharmacology - 21.12.2018
Novartis receives European Commission (EC) approval for expanded indication for Kisqali (ribociclib)
Basel, December 21, 2018 - Novartis today announced that the European Commission (EC) approved an expanded indication for Kisqali †(ribociclib), the CDK4/6 inhibitor with the largest body of first-li

Innovation / Technology - Careers / Employment - 21.12.2018

Astronomy / Space Science - 20.12.2018

Pharmacology - Health - 20.12.2018
Novartis announces offer to acquire CellforCure to expand manufacturing capacity for innovative cell and gene therapies
Proposed acquisition builds on existing agreement with CellforCure for contract manufacturing of Novartis leading CAR-T cell therapy Kymriah (tisagenlecleucel) and recent successful completion of tec

Pharmacology - Business / Economics - 20.12.2018

Business / Economics - Innovation / Technology - 19.12.2018

Careers / Employment - 18.12.2018

Environment - 17.12.2018
Preserving soil quality in the long term
Preserving soil quality in the long term
The National Research Programme "Sustainable Use of Soil Resources" (NRP 68) proposes various measures to safeguard soil quality in Switzerland in the long term. The Centre for Development and Environment (CDE) and the Institute of Geography have investigated the impacts of soil use by Switzerland abroad.

Chemistry - 17.12.2018

Health - Pharmacology - 17.12.2018
PRIME designation granted by European Medicines Agency for Roche’s risdiplam for treatment of spinal muscular atrophy (SMA)
PRIME designation granted by European Medicines Agency for Roche's risdiplam for treatment of spinal muscular atrophy (SMA) Risdiplam has the potential to be the first oral medicine for the treatment

Environment - Health - 14.12.2018

Materials Science - Administration - 14.12.2018

Business / Economics - Computer Science / Telecom - 13.12.2018

Pharmacology - Administration - 13.12.2018
Novartis receives European Commission approval for self-administration of Xolair across all indications
The EC approval underscores the long-term safety and efficacy of Xolair demonstrated in clinical studies and by 13 years of real-world use in Europe † Xolair (omalizumab) prefilled syringe (PFS) is t

Architecture - 13.12.2018
Mario Botta: "I'd like to create a monastery"
Throughout his 50-year-long career, architect Mario Botta has seen his profession undergo profound change, from the introduction of modern styles to the advent of post-modernism.

Academic Rankings - 11.12.2018

Pharmacology - Health - 10.12.2018
Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O(TM) to Treat Opioid Use Disorder
ReSET-O TM is the first FDA-cleared Prescription Digital Therapeutic (PDT) for patients with Opioid Use Disorder Pear Therapeutics is leading the development of a new therapeutic class with two FDA-a

Innovation / Technology - 10.12.2018

Transport - 10.12.2018
Reserve your driving time to reduce traffic congestion
For his thesis, EPFL PhD student RaphaŽl Lamotte studied rush-hour traffic congestion. He suggests implementing a system whereby commuters reserve time on a special traffic lane - like booking a seat on a flight - to help cities accommodate a growing number of car-sharing programs and, eventually, self-driving cars.

Life Sciences - Environment - 10.12.2018
The Fascinating World of Insects
The Fascinating World of Insects
Highlighting diversity, arousing fascination and raising awareness of the vital tasks that insects perform in nature.

Health - Pharmacology - 08.12.2018
Novartis data demonstrates consistent efficacy and tolerability of Kisqali combination therapy in HR+/HER2- advanced breast cancer in patients with difficult-to-treat visceral disease
† Subgroup analyses of three pivotal Phase III MONALEESA trials showed Kisqali plus endocrine therapy extended PFS in all patients with and without visceral involvement compared to endocrine therapy

Computer Science / Telecom - 07.12.2018
"Data protection policies that seem clear are often ambiguous"
A new EU regulation that went into effect in May has prompted consumers to pay more attention to how websites use the personal data they collect. With Polisis, an AI-based program developed at EPFL, consumers can get quick, easy-to-read summaries of websites' data protection policies. And the program is becoming highly popular - EPFL's Technology Transfer Office has received numerous license requests.
1 2 3 4 5 7 Next »